1. Home
  2. MRCY vs PTCT Comparison

MRCY vs PTCT Comparison

Compare MRCY & PTCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mercury Systems Inc

MRCY

Mercury Systems Inc

SELL

Current Price

$78.01

Market Cap

5.0B

Sector

N/A

ML Signal

SELL

Logo PTC Therapeutics Inc.

PTCT

PTC Therapeutics Inc.

SELL

Current Price

$63.51

Market Cap

5.5B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MRCY
PTCT
Founded
1981
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.0B
5.5B
IPO Year
1997
2006

Fundamental Metrics

Financial Performance
Metric
MRCY
PTCT
Price
$78.01
$63.51
Analyst Decision
Buy
Buy
Analyst Count
11
14
Target Price
★ $114.80
$101.07
AVG Volume (30 Days)
568.9K
★ 1.2M
Earning Date
11-03-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
23.08
★ 264.48
EPS
N/A
★ 0.90
Revenue
★ $983,622,000.00
$264,734,000.00
Revenue This Year
$10.46
N/A
Revenue Next Year
$11.44
$9.26
P/E Ratio
★ N/A
$71.38
Revenue Growth
7.85
★ 36.19
52 Week Low
$65.04
$61.23
52 Week High
$128.45
$90.87

Technical Indicators

Market Signals
Indicator
MRCY
PTCT
Relative Strength Index (RSI) 35.02 40.49
Support Level $73.38 $62.46
Resistance Level $89.06 $72.86
Average True Range (ATR) 2.31 2.00
MACD 0.00 0.19
Stochastic Oscillator 7.71 38.57

Price Performance

Historical Comparison
MRCY
PTCT

About MRCY Mercury Systems Inc

Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The company views its operations and manages its business in one operating segment: life science, which is focused on the discovery, development and commercialization of the company's clinically differentiated medicines that provide benefits to patients with rare disorders.

Share on Social Networks: